BioPharm Licensing

Venue: London

Location: London, United Kingdom

Event Date/Time: Nov 29, 2004 End Date/Time: Nov 30, 2004
Report as Spam


This timely and important C5 event has been specifically designed to provide you with an intensive and thorough review and update of the critical issues that arise in virtually all biopharm licensing transactions. The conference brings together a distinguished faculty of leading experts from companies in the pharmaceutical and biotechnology industries, including:
Aventis, GPC Biotech, Pfizer, Cancer Research Technology, Biovex, De Novo
Pharmaceuticals, Cambridge Healthcare & Biotech, Amersham Biosciences, Bayer Cropscience and AstraZeneca.

You will also hear from many of the leading lawyers in private practice. The conference will address a range of relevant issues and subjects including:
• Pharma and Biotech perspectives on valuation
• Expert advice on how to conduct your due diligence successfully
• A detailed analysis of a license agreement
• The key considerations when drafting royalties
• The licensing impact of EU enlargement

C5's conference on BioPharm Licensing is the one stop shop for anyone involved in licensing biotechnology to gain the updates, insights and expert knowledge required to stay ahead of the game.

EF International has changed its name to C5 to reflect the consolidation of its 5 conference groups across 5 continents.